Welcome to our dedicated page for SIGA Technologies news (Ticker: $SIGA), a resource for investors and traders seeking the latest updates and insights on SIGA Technologies stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SIGA Technologies's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SIGA Technologies's position in the market.
SIGA Technologies, Inc. reported strong financial results for Q1 2024, with $24 million in product sales and $11 million in pre-tax operating income, showcasing growth over the previous year. The company highlighted focus on financial and operational excellence, TPOXX® franchise value, and team resilience. Recent developments include a new drug application in Japan and an amendment with Meridian Medical Technologies. SIGA also delivered $24 million of oral TPOXX in Q1, with a special cash dividend of $0.60 per share declared. The conference call and webcast to provide a business update are scheduled for May 7, 2024.
SIGA Technologies, a pharmaceutical company, will host a business update call on May 7, 2024, following the release of their first-quarter financial results. The call will feature the CEO and CFO and will be available via webcast and conference call. Participants can access the call through the company's website or by dialing in. A replay will be available for two weeks.
